Luminex–JPMorgan Chase: investor conference, 202101 supply service Luminex presents at JP Morgan Healthcare Conference 2021

	Period	2021-01-13
	Partner, 1st	Luminex Corporation (Nasdaq: LMNX)
	Group	Luminex (Group)
	Partner, 2nd	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL
	Product 2	xMAP® technology (Luminex)
	Person	Shamir, Nachum (Homi) (Luminex 201605 CEO)
	Person 2	Currie, Harriss T. (Luminex 200805 CFO)

Luminex Corporation. (12/16/20). "Press Release: Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference". Austin, TX.

Luminex Corporation (Nasdaq: LMNX) today announced that Nachum "Homi" Shamir, Chairman, CEO and President, and Harriss Currie, Senior Vice President and CFO, will present at the 39th Annual J.P. Morgan Healthcare Conference, to be held virtually, on January 13, 2021 at 3:30 p.m. Central Time. A live webcast of the Luminex presentation may be accessed at the company's website at http://www.luminexcorp.com. The presentation will be archived for six months on the website using the 'replay' link.

About Luminex Corporation

At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.

Contact:

Harriss Currie
Senior Vice President and Chief Financial Officer
512-219-8020
hcurrie@luminexcorp.com

Carla Stanaford
Investor Relations
937-469-2120
cstanaford@luminexcorp.com